The PD-L1 Expression Among Triple-Negative Breast Cancer Patients in Universitas Sumatera Utara Teaching Hospital, Indonesia

BACKGROUND: The emerging role of precision medicine among in oncologic science is a potentially explorable area to solve long-standing implication of triple-negative breast cancer (TNBC)’s management, especially by identifying programmed cell death ligand-1 (PD-L1) in its population. OBJECTIVE: To d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermansyah, Dedy, Kurniawan, Dede, Lesmana, Daniel KristianPrawira, Simamora, Yolanda Rahayu, Paramita, Desiree Anggia, Siregar, Edwin Saleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical sciences 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665422/
https://www.ncbi.nlm.nih.gov/pubmed/36467323
http://dx.doi.org/10.5455/aim.2022.30.308-311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665422/
https://www.ncbi.nlm.nih.gov/pubmed/36467323
http://dx.doi.org/10.5455/aim.2022.30.308-311

Ejemplares similares